XP
Earnings company data as of 4:49 AM ET 10/23
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 16 Nov | EPS | 0.52 | — | — |
| Rev | — | — | — | ||
| FY2026 Q2 | 17 Aug | EPS | 0.51 | — | — |
| Rev | — | $128.9M | — |
Insider trades
Open-market buys and sales by XP's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $2.4M sold by 1 insider outside a trading plan
- None no planned (10b5-1) sales
-
Bruno Constantino Alexandre Dos Santos DirectorSale$2.4M 123,257 shares at $19.58 7.6% of stakeTraded Sep 16 Filed Sep 17
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 6-K | Filing Doc | ||
| 424B7 | Filing Doc | ||
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| 424B7 | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 6-K | Filing Doc | ||
| 20-F | Filing Doc | ||
| 6-K | Filing Doc | ||
| SCHEDULE 13D/A | — | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.